Home/Pipeline/Flaminal

Flaminal

Acute and Chronic Wounds

CommercialActive

Key Facts

Indication
Acute and Chronic Wounds
Phase
Commercial
Status
Active
Company

About Flen Health

Flen Health is a commercial-stage, privately-held medical device company focused on advanced wound and skin care. With a core biotechnological approach, its product portfolio, including Flaminal and Flamigel, addresses a range of conditions from chronic wounds to radiotherapy-induced skin damage. The company has established a direct commercial presence in multiple European countries and employs over 110 people, leveraging over two decades of experience to serve healthcare professionals and patients.

View full company profile

Other Acute and Chronic Wounds Drugs

DrugCompanyPhase
LiquiCell Wound CareBirchwood LaboratoriesCommercial